Compounds > triflusal
Page last updated: 2024-08-21

triflusal and sirolimus

triflusal has been researched along with sirolimus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Arumugam, S; Boey, FY; Huang, Y; Mohanty, M; Umashankar, PR; Venkatraman, SS1
Arumugam, S; Boey, FY; Huang, Y; Khanolkar, L; Lahti, EM; Mohanty, M; Umashankar, PR; Vaishnav, S; Venkatraman, SS1
Berenguer, A; de la Torre Hernandez, JM; Diaz, JF; Garcia Del Blanco, B; Gomez-Lara, J; Gomez-Menchero, A; Moreno, R; Muñoz-Garcia, E; Otaegui, I; Rondan, J; Rumoroso, JR; Sainz-Laso, F; Subinas, A; Zueco, J1

Other Studies

3 other study(ies) available for triflusal and sirolimus

ArticleYear
The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model.
    Journal of interventional cardiology, 2009, Volume: 22, Issue:5

    Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Chromium Alloys; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Drug-Eluting Stents; Immunosuppressive Agents; Platelet Aggregation Inhibitors; Prosthesis Design; Salicylates; Sirolimus; Swine; Thrombosis; Treatment Outcome

2009
In vitro and in vivo performance of a dual drug-eluting stent (DDES).
    Biomaterials, 2010, Volume: 31, Issue:15

    Topics: Animals; Antibiotics, Antineoplastic; Coated Materials, Biocompatible; Drug Delivery Systems; Drug-Eluting Stents; Humans; Hyperplasia; Materials Testing; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Salicylates; Sirolimus; Surface Properties; Swine; Thrombosis

2010
First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study.
    Cardiovascular revascularization medicine : including molecular interventions, 2021, Volume: 32

    Topics: Coronary Vessels; Drug-Eluting Stents; Humans; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Salicylates; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome

2021